574 related articles for article (PubMed ID: 33345256)
21. Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms.
Pagano K; Tomaselli S; Molinari H; Ragona L
Front Neurosci; 2020; 14():619667. PubMed ID: 33414705
[TBL] [Abstract][Full Text] [Related]
22. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective.
Ferrer I
Free Neuropathol; 2022 Jan; 3():. PubMed ID: 37284149
[TBL] [Abstract][Full Text] [Related]
24. New insights into atypical Alzheimer's disease in the era of biomarkers.
Graff-Radford J; Yong KXX; Apostolova LG; Bouwman FH; Carrillo M; Dickerson BC; Rabinovici GD; Schott JM; Jones DT; Murray ME
Lancet Neurol; 2021 Mar; 20(3):222-234. PubMed ID: 33609479
[TBL] [Abstract][Full Text] [Related]
25. Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer's disease.
D'Andrea C; Cazzaniga FA; Bistaffa E; Barucci A; de Angelis M; Banchelli M; Farnesi E; Polykretis P; Marzi C; Indaco A; Tiraboschi P; Giaccone G; Matteini P; Moda F
Transl Neurodegener; 2023 Jul; 12(1):35. PubMed ID: 37438825
[TBL] [Abstract][Full Text] [Related]
26. Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons.
Meng X; Song Q; Liu Z; Liu X; Wang Y; Liu J
Front Aging Neurosci; 2024; 16():1400544. PubMed ID: 38808033
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
[TBL] [Abstract][Full Text] [Related]
28. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
29. Huanglian Jiedu decoction alleviates neurobehavioral damage in mice with chronic alcohol exposure through the RAS-RAF-MEK-ERK pathway.
Chen Y; Jiang L; Li M; Shen Y; Liu S; Yang D
Heliyon; 2024 Apr; 10(8):e29556. PubMed ID: 38644875
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer's disease.
Munafò A; Cantone AF; Di Benedetto G; Torrisi SA; Burgaletto C; Bellanca CM; Gaudio G; Broggi G; Caltabiano R; Leggio GM; Bernardini R; Cantarella G
Front Pharmacol; 2024; 15():1386224. PubMed ID: 38595916
[No Abstract] [Full Text] [Related]
31. OCT Imaging in Murine Models of Alzheimer's Disease in a Systematic Review: Findings, Methodology and Future Perspectives.
Sánchez-Puebla L; López-Cuenca I; Salobrar-García E; Ramírez AI; Fernández-Albarral JA; Matamoros JA; Elvira-Hurtado L; Salazar JJ; Ramírez JM; de Hoz R
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540142
[TBL] [Abstract][Full Text] [Related]
32. Two decades of [
Myburgh PJ; Solingapuram Sai KK
Am J Nucl Med Mol Imaging; 2024; 14(1):48-62. PubMed ID: 38500746
[TBL] [Abstract][Full Text] [Related]
33. Antibodies Raised Against an Aβ Oligomer Mimic Recognize Pathological Features in Alzheimer's Disease and Associated Amyloid-Disease Brain Tissue.
Kreutzer AG; Parrocha CMT; Haerianardakani S; Guaglianone G; Nguyen JT; Diab MN; Yong W; Perez-Rosendahl M; Head E; Nowick JS
ACS Cent Sci; 2024 Jan; 10(1):104-121. PubMed ID: 38292607
[TBL] [Abstract][Full Text] [Related]
34. Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer's Disease.
Tan NA; Carpio AMA; Heller HC; Pittaras EC
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254938
[TBL] [Abstract][Full Text] [Related]
35. Exploring the complexities of 1C metabolism: implications in aging and neurodegenerative diseases.
Bou Ghanem A; Hussayni Y; Kadbey R; Ratel Y; Yehya S; Khouzami L; Ghadieh HE; Kanaan A; Azar S; Harb F
Front Aging Neurosci; 2023; 15():1322419. PubMed ID: 38239489
[TBL] [Abstract][Full Text] [Related]
36. Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer's Disease.
Kozin SA; Kechko OI; Adzhubei AA; Makarov AA; Mitkevich VA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203242
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease: a continuum with visual involvements.
Elvira-Hurtado L; López-Cuenca I; de Hoz R; Salas M; Sánchez-Puebla L; Ramírez-Toraño F; Matamoros JA; Fernández-Albarral JA; Rojas P; Alfonsín S; Delgado-Losada ML; Ramírez AI; Salazar JJ; Maestu F; Gil P; Ramírez JM; Salobrar-García E
Front Psychol; 2023; 14():1124830. PubMed ID: 37484098
[TBL] [Abstract][Full Text] [Related]
38. Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future.
Zhang Y; Chen H; Li R; Sterling K; Song W
Signal Transduct Target Ther; 2023 Jun; 8(1):248. PubMed ID: 37386015
[TBL] [Abstract][Full Text] [Related]
39. Going beyond established model systems of Alzheimer's disease: companion animals provide novel insights into the neurobiology of aging.
de Sousa AA; Rigby Dames BA; Graff EC; Mohamedelhassan R; Vassilopoulos T; Charvet CJ
Commun Biol; 2023 Jun; 6(1):655. PubMed ID: 37344566
[TBL] [Abstract][Full Text] [Related]
40. Neuropathology of the Alzheimer's continuum: an update.
Jellinger KA
Free Neuropathol; 2020 Jan; 1():. PubMed ID: 37283686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
